FOURTH
QUARTER 2022
Earnings conference call
February 8, 2023
KAREN S. LYNCH
President | and |
Chief Executive Officer |
SHAWN M. GUERTIN
Executive Vice President and Chief Financial Officer
Cautionary statement
concerning forward- looking statements
This presentation includes forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-lookingstatements made by or on behalf of CVS Health Corporation ("CVS Health"). By their nature, all forward-lookingstatements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may also differ materially from those contemplated by the forward- looking statements due to the risks and uncertainties related to the proposed acquisition of Oak Street Health, Inc., the pending acquisition of Signify Health, Inc. and the COVID-19pandemic, including the potential emergence of additional variants, vaccine and testing protocols, government testing initiatives, the geographies impacted by and the severity and duration of the pandemic, the pandemic's impact on the U.S. and global economies and consumer behavior and health care utilization patterns, and the timing, scope and impact of stimulus legislation and other federal, state and local governmental responses to the pandemic, as well as the risks and uncertainties described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section
and under the heading "Cautionary Statement Concerning Forward-Looking Statements" in our most recent Annual Report on Form 10-K, our recent Current Reports on Form 8-K, and this morning's earnings press release.
This presentation includes non-GAAP financial measures that we use to describe our company's performance. In accordance with SEC regulations, you can find the definitions of these non-GAAP measures, as well as reconciliations to the most directly comparable GAAP measures, on the Investor Relations portion of our website.
2 ©2023 CVS Health and/or one of its affiliates.
[Link to our non-GAAP Reconciliations]
Financial highlights
Q4 2022 Adjusted EPS of $1.99 exceeded expectations; Reaffirming 2023 Adjusted EPS guidance to between $8.70 - $8.90
$1.99
Q4 2022 Adjusted EPS
Exceeded expectations
9.5%
Q4 revenue growth
Reflects growth across all segments
Deployed capital to generate
Evidence
our strategy and execution is delivering value across the health care system for
our customers, our communities, our colleagues and our stockholders
FY 2023 guidance
Total company revenue
$333B - $339B
Total company adjusted operating income
$17.3B - $17.7B
Total company adjusted EPS
$8.70 - $8.90
Total operating cash flow
$12.5B - $13.5B
shareholder value
Returned $719 million to shareholders through quarterly dividend
Executed $1.5 billion of share repurchases
3 ©2023 CVS Health and/or one of its affiliates.
1
2
Unify our business around the consumer
health experience and | 3 |
scale new sources of value
4
5
4 ©2023 CVS Health and/or one of its affiliates.
Grow our foundational businesses
Advance care delivery and health services offerings
Reimagine our omnichannel health experience
Harness cutting-edge tech to streamline and simplify
Empower our people and culture
2022 Financial Review
5 ©2023 CVS Health and/or one of its affiliates.
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
CVS Health Corporation published this content on 08 February 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 February 2023 12:43:15 UTC.